BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 28865022)

  • 1. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers.
    Ishizuka Y; Shimizu H; Takagi E; Kato M; Yamagata H; Mikuni M; Shirao T
    Neurochem Int; 2014 Oct; 76():114-21. PubMed ID: 25058791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life.
    Aoki C; Sherpa AD
    Adv Exp Med Biol; 2017; 1006():119-139. PubMed ID: 28865018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of the distribution of spines containing drebrin A in the sensory cortex layer I of mice expressing mutated APP and PS1 genes.
    Mahadomrongkul V; Huerta PT; Shirao T; Aoki C
    Brain Res; 2005 Dec; 1064(1-2):66-74. PubMed ID: 16325786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.
    Lacor PN; Buniel MC; Furlow PW; Clemente AS; Velasco PT; Wood M; Viola KL; Klein WL
    J Neurosci; 2007 Jan; 27(4):796-807. PubMed ID: 17251419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
    J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits.
    Kojima N; Shirao T
    Neurosci Res; 2007 May; 58(1):1-5. PubMed ID: 17379343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.
    Zhao L; Ma QL; Calon F; Harris-White ME; Yang F; Lim GP; Morihara T; Ubeda OJ; Ambegaokar S; Hansen JE; Weisbart RH; Teter B; Frautschy SA; Cole GM
    Nat Neurosci; 2006 Feb; 9(2):234-42. PubMed ID: 16415866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease.
    Gordon-Weeks PR
    Brain Res Bull; 2016 Sep; 126(Pt 3):293-299. PubMed ID: 27365229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
    Viola KL; Velasco PT; Klein WL
    J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Drebrin in Synaptic Plasticity.
    Sekino Y; Koganezawa N; Mizui T; Shirao T
    Adv Exp Med Biol; 2017; 1006():183-201. PubMed ID: 28865021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
    Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
    J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.